Home > Income Statement > AARTI DRUGS

AARTI DRUGS
Revenue

    Back to Income Statement
AARTI DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹2,565 Cr₹2,387 Cr₹2,529 Cr₹2,716 Cr₹2,489 Cr

What is the latest Revenue of AARTI DRUGS ?

The latest Revenue ratio of AARTI DRUGS is ₹2,565 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹2,565 Cr
Mar2025₹2,387 Cr
Mar2024₹2,529 Cr
Mar2023₹2,716 Cr
Mar2022₹2,489 Cr

How is Revenue of AARTI DRUGS Trending?

Years Revenue % Change
Mar2026 ₹2,565 Cr
7.47
Mar2025 ₹2,387 Cr
-5.60
Mar2024 ₹2,529 Cr
-6.90
Mar2023 ₹2,716 Cr
9.14
Mar2022 ₹2,489 Cr -

Compare Revenue of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹4,559.1 Cr -1.6% 28.1% 9.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,228.0 Cr 1.2% 9.1% 6.6% Stock Analytics
DIVIS LABORATORIES ₹296,741.0 Cr -2.7% 22.2% 70% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,413.0 Cr -1% 2% 20.8% Stock Analytics
DR REDDYS LABORATORIES ₹116,771.0 Cr 1.5% 13% 12.1% Stock Analytics
CIPLA ₹114,397.0 Cr 1.7% 7.8% -7.3% Stock Analytics


AARTI DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

-1.6%

28.1%

9.1%

SENSEX

1.4%

12.4%

-1.7%


You may also like the below Video Courses